VivoSeq
Other

Menopausal Symptoms

0

Pipeline Programs

2

Active Trials

2

Companies Involved

Menopausal Symptoms is an early-stage landscape with 0 programs across 2 companies. The most active players are Novo Nordisk, Pfizer.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

16

clinical trials

Completed11 · 69%
Not yet recruiting2 · 13%
Unknown status2 · 13%
Terminated1 · 6%

Trial Activity

16 trials

Study the Effect of Danggui Buxue Tang on Menopausal Symptoms
Completed··Phase 2·NCT00421564·100 enrolled
Acupuncture for Relieving Perimenopausal Symptoms
Completed··Phase 2/3·NCT01933204·220 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)